A detailed history of Private Capital Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 208 shares of ARWR stock, worth $3,856. This represents 0.01% of its overall portfolio holdings.

Number of Shares
208
Previous 208 -0.0%
Holding current value
$3,856
Previous $10,000 30.0%
% of portfolio
0.01%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

BUY
$39.62 - $69.97 $79 - $139
2 Added 0.97%
208 $10,000
Q2 2021

Jul 26, 2021

SELL
$62.15 - $90.32 $621 - $903
-10 Reduced 4.63%
206 $17,000
Q1 2021

Apr 12, 2021

SELL
$61.35 - $90.47 $15,337 - $22,617
-250 Reduced 53.65%
216 $14,000
Q4 2020

Jan 26, 2021

BUY
$43.82 - $85.37 $438 - $853
10 Added 2.19%
466 $36,000
Q3 2020

Nov 12, 2020

BUY
$33.21 - $51.27 $1,693 - $2,614
51 Added 12.59%
456 $20,000
Q2 2020

Aug 13, 2020

BUY
$26.12 - $43.27 $208 - $346
8 Added 2.02%
405 $17,000
Q1 2020

May 07, 2020

SELL
$20.56 - $63.12 $102 - $315
-5 Reduced 1.24%
397 $11,000
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $1,688 - $4,380
60 Added 17.54%
402 $25,000
Q3 2019

Nov 13, 2019

BUY
$26.26 - $34.86 $8,980 - $11,922
342 New
342 $10,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $1.96B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.